Difficulty-Estimated Policy Optimization
Abstract
Recent advancements in Large Reasoning Models (LRMs), exemplified by DeepSeek-R1, have underscored the potential of scaling inference-time compute through Group Relative Policy Optimization (GRPO). However, GRPO frequently suffers from gradient signal attenuation when encountering problems that are either too trivial or overly complex. In these scenarios, the disappearance of inter-group advantages makes the gradient signal susceptible to noise, thereby jeopardizing convergence stability. While variants like DAPO attempt to rectify gradient vanishing, they do not alleviate the substantial computational overhead incurred by exhaustive rollouts on low-utility samples. In this paper, we propose Difficulty-Estimated Policy Optimization (DEPO), a novel framework designed to optimize the efficiency and robustness of reasoning alignment. DEPO integrates an online Difficulty Estimator that dynamically assesses and filters training data before the rollout phase. This mechanism ensures that computational resources are prioritized for samples with high learning potential. Empirical results demonstrate that DEPO achieves up to a 2x reduction in rollout costs without compromising model performance. Our approach significantly lowers the computational barrier for training high-performance reasoning models, offering a more sustainable path for reasoning scaling. Code and data will be released upon acceptance.
Read the paper
Related studies
- Meta-analysis and the science of research synthesis
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- Cluster Randomized Controlled Trial
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
- Disease Free Survival and Local Recurrence for Laparoscopic Resection Compared to Open Resection of Stage II-III Rectal Cancer: Follow up Results of the ACOSOG Z6051 Randomized Controlled Trial
- The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.